Perimenopause & Menopause:
Why Early Assessment Changes Everything

Understanding Perimenopause & Menopause

Menopause — defined as twelve consecutive months without a menstrual period — is a natural biological transition. But for many women, the journey begins far earlier than they expect. Perimenopause, the transitional phase that can start in a woman's late thirties or early forties, is often the more turbulent and disruptive period, yet it is consistently under-recognised and under-treated.

During perimenopause, oestrogen, progesterone, and testosterone levels fluctuate erratically before declining. These hormonal shifts can affect virtually every organ system — the brain, heart, bones, skin, gut, and urogenital tract — producing a constellation of symptoms that are frequently attributed to stress, low mood, or simply "getting older."

The average age of menopause in the UK is 51, but perimenopausal symptoms can begin 4–10 years before that final period. That is a significant window of time in which women deserve active support, not watchful waiting.

The Symptom Spectrum

Symptoms vary enormously between individuals. Some women experience a smooth transition; others find their quality of life profoundly affected. Common presentations include:

Why Early Assessment Matters

One of the most important things I tell my patients is this: menopause is not just a reproductive milestone — it is a major health event. The years around the menopause transition represent a critical window for protecting long-term health, and early, proactive assessment is key to making the most of that window.

The Benefits of Symptom Control

• Bone protection. HRT initiated early in the menopause transition is one of the most effective strategies for preserving bone mineral density and reducing osteoporotic fracture risk.

• Cardiovascular health. Evidence supports a "timing hypothesis" — oestrogen therapy initiated early, before significant atherosclerotic disease develops, may reduce cardiovascular risk rather than increase it.

• Cognitive wellbeing. Addressing sleep disruption, brain fog, and mood changes early prevents years of unnecessary suffering and supports cognitive resilience.

• Quality of life. Effective symptom control has a measurable impact on relationships, professional performance, mental health, and overall wellbeing. This is not vanity — it is clinical necessity.

• Genitourinary health. Localised vaginal oestrogen, initiated early, prevents progressive atrophy that becomes increasingly difficult to reverse with time.

• Metabolic health. Oestrogen influences insulin sensitivity, body composition, and lipid metabolism. Early intervention supports a more favourable metabolic profile through midlife.

HRT Options: A Personalised Approach

Hormone Replacement Therapy has undergone a significant rehabilitation in clinical thinking over the past decade. Early fears, largely stemming from the misinterpreted WHI study of 2002, led to decades of under-prescribing that caused real harm to women's health. Today, current NICE guidance (NG23) and the British Menopause Society clearly support HRT as safe and effective for the majority of women, with benefits that substantially outweigh risks for most women under 60 or within ten years of menopause onset.

At Hinchley Medical, I do not take a one-size-fits-all approach. HRT is prescribed following a thorough clinical assessment, comprehensive blood testing, and an open discussion of individual risk factors, preferences, and goals.

HRT Options at a Glance

Body-identical HRT — using oestradiol and micronised progesterone that are structurally identical to the hormones produced by the body — is my preferred approach for most patients. It is distinct from older synthetic progestogens and carries a more favourable safety and tolerability profile.

Testosterone Therapy in Women

Testosterone is often overlooked in the context of female hormonal health, yet it is one of the most clinically significant hormones women produce — and one of the first to decline, typically from the mid-thirties onwards. Its fall accelerates around menopause, and the resulting deficiency can be responsible for some of the most debilitating symptoms women experience: profound fatigue, loss of libido, reduced cognitive sharpness, and a persistent flatness of mood and motivation that fails to respond to oestrogen alone.

How We Prescribe Testosterone at Hinchley Medical

In the UK, there is currently no licensed testosterone product specifically formulated for women. At Hinchley Medical, I prescribe testosterone using established, evidence-based protocols — typically as a compounded topical cream or using a low-dose preparation from a reputable licensed source, applied to the skin in a small daily amount.

• Baseline blood testing before prescribing, including free and total testosterone, SHBG, and relevant metabolic markers.

• Individualised dosing — formulated to restore levels to the upper end of the normal female physiological range, not supraphysiological.

• Regular monitoring with follow-up blood tests at 3 and 6 months, then annually, to ensure levels remain safe and therapeutic.

• Compounded formulations available for patients requiring specific concentrations or combinations not available through standard preparations.

• Holistic review — testosterone is prescribed as part of a complete hormonal strategy, not in isolation.

Women often report the first tangible improvements with testosterone therapy within six to eight weeks: a return of energy, sharper thinking, renewed motivation, and — for many — a meaningful restoration of intimacy and connection. These are not trivial outcomes. They represent a return to self.

The Advantage of Private Healthcare for Hormonal Health

I am proud to work within the NHS, and I believe in its principles deeply. But I would be doing my patients a disservice if I didn't acknowledge the very real constraints that NHS primary care operates under — and the ways in which private healthcare can meaningfully bridge those gaps for women navigating this transition.

What Comprehensive Testing Can Reveal

Many women arrive having been told their "bloods are normal." Normal on a basic screen is not the same as optimal. A comprehensive hormonal and metabolic assessment can identify subclinical thyroid dysfunction masquerading as perimenopausal fatigue; low testosterone levels explaining persistent cognitive symptoms despite adequate oestrogen; vitamin D deficiency compounding bone and mood concerns; elevated inflammatory markers pointing to underlying metabolic risk; or adrenal insufficiency contributing to fatigue and poor stress resilience.

This level of diagnostic rigour is not a luxury — it is the standard of care every woman deserves, and it is what we deliver at Hinchley Medical.

Starting the Conversation

If you are in your late thirties, forties, or beyond, and something does not feel quite right — your sleep is disrupted, your mood is different, your energy has shifted, your body feels unfamiliar — please do not wait. These symptoms are not inevitable. They are not something to simply "push through." They are signals from your body, and they deserve a proper clinical response.

The conversation around menopause has shifted enormously in recent years, and rightly so. We now have robust evidence, safe and effective treatments, and a much richer understanding of how to support women through this transition and beyond. At Hinchley Medical, I am here to have that conversation with you — thoroughly, honestly, and with your long-term health and wellbeing at the centre of everything we do.